Your browser doesn't support javascript.
loading
Promiscuous antibodies characterised by their physico-chemical properties: From sequence to structure and back.
Laffy, Julie M J; Dodev, Tihomir; Macpherson, Jamie A; Townsend, Catherine; Lu, Hui Chun; Dunn-Walters, Deborah; Fraternali, Franca.
Affiliation
  • Laffy JMJ; Randall Division of Cell and Molecular Biophysics, King's College London, UK.
  • Dodev T; Department of Immunobiology, King's College London, UK.
  • Macpherson JA; Randall Division of Cell and Molecular Biophysics, King's College London, UK.
  • Townsend C; Department of Immunobiology, King's College London, UK.
  • Lu HC; Randall Division of Cell and Molecular Biophysics, King's College London, UK.
  • Dunn-Walters D; Department of Immunobiology, King's College London, UK; Faculty of Health and Medical Sciences, University of Surrey, UK.
  • Fraternali F; Randall Division of Cell and Molecular Biophysics, King's College London, UK. Electronic address: franca.fraternali@kcl.ac.uk.
Prog Biophys Mol Biol ; 128: 47-56, 2017 09.
Article in En | MEDLINE | ID: mdl-27639634
ABSTRACT
Human B cells produce antibodies, which bind to their cognate antigen based on distinct molecular properties of the antibody CDR loop. We have analysed a set of 10 antibodies showing a clear difference in their binding properties to a panel of antigens, resulting in two subsets of antibodies with a distinct binding phenotype. We call the observed binding multiplicity 'promiscuous' and selected physico-chemical CDRH3 characteristics and conformational preferences may characterise these promiscuous antibodies. To classify CDRH3 physico-chemical properties playing a role in their binding properties, we used statistical analyses of the sequences annotated by Kidera factors. To characterise structure-function requirements for antigen binding multiplicity we employed Molecular Modelling and Monte Carlo based coarse-grained simulations. The ability to predict the molecular causes of promiscuous, multi-binding behaviour would greatly improve the efficiency of the therapeutic antibody discovery process.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chemical Phenomena / Antibodies / Antibody Specificity Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Prog Biophys Mol Biol Year: 2017 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chemical Phenomena / Antibodies / Antibody Specificity Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Prog Biophys Mol Biol Year: 2017 Document type: Article Affiliation country: Reino Unido